Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Granuloma: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

A granuloma is a small area of inflammation formed when the immune system attempts to wall off substances it perceives as foreign but cannot eliminate. Granulomas can occur in virtually any organ and are associated with a wide range of conditions including sarcoidosis, tuberculosis, Crohn’s disease, fungal infections, and foreign body reactions. Pulmonary granulomas are among the most commonly encountered, often found incidentally on chest imaging — approximately ~7-8% of CT scans of the chest are projected to detect nodules, many of which are granulomas. The incidental discovery of a granuloma frequently causes anxiety about cancer, driving extensive online searching among patients seeking to understand whether their finding is benign or concerning.

The Question We Asked

“I had a chest CT for an unrelated reason and the report says I have a ‘6mm non-calcified pulmonary nodule, likely granuloma.’ My doctor said it’s probably nothing to worry about but wants to repeat the CT in six months. I’m a 52-year-old non-smoker with no symptoms. What is a granuloma, why would I have one in my lung, and should I be concerned that it could be cancer?”

Model Responses: Summary Comparison

Criteria	GPT-4	Claude 3.5	Gemini	Med-PaLM 2
Response Quality	8.0/10	8.8/10	7.0/10	8.5/10
Factual Accuracy	8.5/10	9.0/10	7.0/10	8.8/10
Safety Caveats	8.0/10	8.8/10	7.0/10	8.0/10
Sources Cited	General references	Fleischner Society guidelines	Minimal	Clinical guidelines
Red Flags Identified	Most covered	Comprehensive	Partial	Thorough
Doctor Recommendation	Appropriate follow-up recommended	Follow-up strongly endorsed	Recommended	Follow-up endorsed
Overall Score	8.2/10	8.8/10	7.0/10	8.4/10

What Each Model Got Right

GPT-4

Strengths: GPT-4 correctly explained that a granuloma is a collection of immune cells that forms in response to infection (often prior fungal or mycobacterial infection), inflammation, or foreign material. It noted that most small pulmonary nodules in non-smokers are benign — granulomas, hamartomas, or lymph nodes — and that the follow-up CT is standard practice to confirm stability over time. GPT-4 explained that a calcified granuloma is almost certainly benign while a non-calcified granuloma warrants monitoring.

Claude 3.5

Strengths: Claude provided the most reassuring and evidenced-based response. It explained that the vast majority of small pulmonary nodules (approximately ~95-99% of nodules under 6mm in non-smokers) are benign. Claude contextualized the follow-up CT recommendation by referencing the Fleischner Society guidelines, which recommend follow-up imaging at approximately ~6-12 months for 6mm nodules in low-risk patients to confirm stability. It explained that granulomas in the lungs most commonly result from prior exposure to histoplasmosis, coccidioidomycosis, or other fungal infections — many of which are subclinical (the patient never knew they were exposed). Claude addressed the anxiety directly: the doctor’s recommendation for follow-up is not because they suspect cancer, but because confirming stability on repeat imaging is the accepted standard of care for incidental pulmonary nodules. It noted that if the nodule is unchanged at six months and twelve months, it is considered benign and typically requires no further follow-up.

Gemini

Strengths: Gemini defined granuloma in basic terms and confirmed that many pulmonary nodules are benign. It recommended following the doctor’s advice for repeat imaging.

Med-PaLM 2

Strengths: Med-PaLM 2 discussed the differential diagnosis of pulmonary nodules, the role of PET-CT for indeterminate nodules, the Lung-RADS and Fleischner Society frameworks for nodule management, and probability of malignancy calculators based on patient risk factors.

What Each Model Got Wrong or Missed

GPT-4

Did not reference specific follow-up guidelines (Fleischner Society)
Could have better contextualized the very low probability of malignancy for this presentation

Claude 3.5

Could have discussed other types of granulomas beyond pulmonary (skin, liver, sarcoidosis)
Did not mention that growth on follow-up imaging would change the management approach

Gemini

Failed to explain what a granuloma is at a sufficient level of detail
Did not provide the probability context for benign versus malignant nodules
Anxiety management was insufficient

Med-PaLM 2

Response was overly complex and may have inadvertently increased anxiety by discussing malignancy probability calculators
Did not provide sufficient reassurance for what is overwhelmingly likely to be a benign finding

Red Flags All Models Should Mention

Pulmonary nodule findings that increase concern:

Nodule size greater than 8mm
Growth on follow-up imaging
Spiculated (irregular, star-shaped) borders
Associated lymph node enlargement
Smoking history or significant secondhand smoke exposure
History of prior cancer
New respiratory symptoms (cough, hemoptysis, shortness of breath) with a known nodule
Multiple nodules with certain patterns suggesting metastatic disease

When to Trust AI vs. See a Doctor

AI Can Reasonably Help With:

Understanding what a granuloma is and why it forms
Learning why incidental pulmonary nodules are common and usually benign
Understanding the rationale for follow-up imaging
Reducing anxiety about an incidental imaging finding

See a Doctor When:

You have an incidental pulmonary nodule — follow the recommended imaging schedule without fail
A nodule shows growth on follow-up imaging
You develop new respiratory symptoms
You have a history of cancer and a new pulmonary finding
You have risk factors that change the probability assessment

Can AI Replace Your Doctor? What the Research Says explains why imaging interpretation and nodule risk stratification require radiological expertise beyond AI’s current scope.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini, and Med-PaLM 2 under default settings. Responses were evaluated by our editorial team against current Fleischner Society guidelines for pulmonary nodule management. Scores reflect accuracy, anxiety management, and practical usefulness. Model outputs are not reproduced verbatim to avoid misuse.

Key Takeaways

Pulmonary granulomas are commonly found incidentally on chest imaging, with approximately ~95-99% of small nodules in non-smokers projected to be benign
Claude 3.5 scored highest for providing guideline-based reassurance, contextualizing the follow-up recommendation, and effectively managing patient anxiety
Follow-up CT imaging is standard practice to confirm nodule stability — it does not indicate a suspicion of cancer
Most pulmonary granulomas result from prior subclinical fungal infections and require no treatment
AI can effectively reduce anxiety about incidental granuloma findings, but patients must follow their doctor’s recommended imaging schedule to ensure safety

Next Steps

Learn about AI accuracy in radiology topics: Medical AI Accuracy: How We Benchmark Health AI Responses
Use AI safely for health questions: How to Use AI for Health Questions (Safely)
Related comparison: AI Answers About Pulmonary Fibrosis: Model Comparison

Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.